Overhaul, a startup developing supply chain risk monitoring software, has raised $55 million in a venture round.

Discover how Kaiser Permanente and Banner Health are investing in a $275 million funding round for healthcare data company Innovaccer.

Pfizer Inc. today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with Bacillus ...

Texas Attorney General Ken Paxton filed a notice of appeal on Wednesday to continue his lawsuit against Pfizer Inc., for its ...

LAS VEGAS & FRANKFURT, Germany--(BUSINESS WIRE)--KION GROUP AG, the Supply Chain Solutions Company ... We combine our strength in technology and leadership in cloud, data and AI with unmatched ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), The ...

Artificial intelligence continues to revolutionize buyer-supplier collaboration and information management, offering transformative opportunities to optimize supply chains.

They even generated clinical results that suggested it might have promise as a weight-loss drug as well — only to have Pfizer, which had agreed to fund the research, withdraw its support ...

The approval positions Alhemo as a competitor to Pfizer’s Hympavzi (marstacimab-hncg), another subcutaneous TFPI inhibitor approved in October 2024. However, Hympavzi is administered weekly and is ...

Pfizer holds exclusive rights to BRAFTOVI in the Middle East, Canada, Latin America, Africa, and the US. Credit: ShU studio/Shutterstock. Pfizer has gained accelerated approval from the US Food and ...

Beata Zawrzel / NurPhoto via Getty Images Pfizer on Tuesday affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.